990 resultados para Friedler, Eric
Resumo:
O objetivo deste trabalho foi identificar isolados brasileiros de Ralstonia solanacearum quanto a filotipos e sequevares, determinar sua diversidade genética, realizar a associação da estrutura genética do patógeno com sua classificação e origem geográfica e identificar um marcador molecular para a diagnose do moko-da-bananeira. Um grupo de 33 isolados de R. solanacearum, da coleção da Embrapa Tabuleiros Costeiros, coletado de diversos hospedeiros, foi caracterizado por meio de PCR em sequência palindrômica extragênica repetitiva (rep-PCR) e RAPD. Deste grupo, 19 perteciam à raça 2 do patógeno e 14 à raça 1, e 15 isolados eram associados à cultura da bananeira. Os filotipos e sequevares foram caracterizados e determinados por PCR Multiplex. Verificou-se que 82% dos isolados pertencem ao filotipo II, e 12% ao filotipo III. Todos os isolados da bananeira pertencem ao filotipo II. Atécnica de RAPD foi eficiente em agrupar os isolados de acordo com sua origem geográfica; entretanto, ela requer um número elevado de marcas moleculares. Foi possível relacionar os isolados pela análise rep-PCR. O iniciador com sequências repetitivas enterobacterianas intergênicas de consenso (ERIC) possibilitou a separação dos isolados de acordo com a raça, eoiniciador REP permitiua discriminação entre os filotipos. Estas duas análises foram as mais informativas.
Resumo:
Une expertise collective sur l'évaluation des risques liés aux nanomatériaux pour la population générale et pour l'environnement a identifié plusieurs centaines de produits de grande consommation contenant des nanomatériaux, présents dans notre quotidien : textiles, cosmétiques, alimentaires, équipements sportifs, matériaux de construction... Des études nouvelles suggèrent la possibilité de risques pour la santé et pour l'environnement de certains produits. Face à cette situation d'incertitude, l'Afsset recommande d'agir sans attendre au nom du principe de précaution et de 1) Rendre obligatoire la traçabilité des nanomatériaux. Cela passe par une obligation de déclaration par les industriels, 2) la mise en place un étiquetage clair qui mentionne la présence de nanomatériaux dans les produits et informe sur la possibilité de relargage à l'usage, 3) d'aller jusqu'à l'interdiction de certains usages des nanomatériaux pour lesquels l'utilité est faible par rapport aux dangers potentiels, 4) l'harmonisation des cadres réglementaires français et européens pour généraliser les meilleures pratiques : déclaration, autorisation, substitution. En particulier, une révision de REACh s'impose pour prendre en compte les nanomatériaux manufacturés de manière spécifique et quel que soit leur tonnage. L'expertise fait également des recommandations pour construire une méthode renouvelée d'évaluation des risques sanitaires qui soit adaptée aux spécificités des nanomatériaux. Pour cela l'Afsset a testé les méthodologies classiques d'évaluation des risques sur 4 produits particuliers et courants : la chaussette antibactérienne (nanoparticules d'argent), le ciment autonettoyant et le lait solaire (nanoparticules de dioxyde de titane), la silice alimentaire à l'état nanométrique. Ces 4 produits représentent bien les voies d'exposition de l'homme (cutanée, inhalation, ingestion) et la possibilité de dispersion environnementale. Ces travaux font apparaître une urgence à faire progresser les connaissances sur les expositions et les dangers potentiels des nanomatériaux. Aujourd'hui, seuls 2% des études publiées sur les nanomatériaux concernent leurs risques pour la santé et l'environnement. Le premier effort devra porter sur la normalisation des caractéristiques des nanomatériaux. Les priorités de la recherche devront cibler la toxicologie, l'écotoxicologie et la mesure des expositions. Enfin, l'Afsset prévoit de s'autosaisir pour définir en 2 ans, avec son groupe de travail, un outil simplifié d'évaluation des risques. Il s'agit d'une grille de cotation des risques qui permet de catégoriser les produits en plusieurs gammes de risques. Face à ce chantier considérable, une mise en réseau entre les organismes européens et internationaux pour se partager le travail est nécessaire. Elle a commencé autour de l'OCDE qui coordonne des travaux d'évaluation des risques et de l'ISO qui travaille à la mise en place de nouvelles normes. [Auteurs]
Resumo:
Tumors in non-Hodgkin lymphoma (NHL) patients are often proximal to the major blood vessels in the abdomen or neck. In external-beam radiotherapy, these tumors present a challenge because imaging resolution prevents the beam from being targeted to the tumor lesion without also irradiating the artery wall. This problem has led to potentially life-threatening delayed toxicity. Because radioimmunotherapy has resulted in long-term survival of NHL patients, we investigated whether the absorbed dose (AD) to the artery wall in radioimmunotherapy of NHL is of potential concern for delayed toxicity. SPECT resolution is not sufficient to enable dosimetric analysis of anatomic features of the thickness of the aortic wall. Therefore, we present a model of aortic wall toxicity based on data from 4 patients treated with (131)I-tositumomab. METHODS: Four NHL patients with periaortic tumors were administered pretherapeutic (131)I-tositumomab. Abdominal SPECT and whole-body planar images were obtained at 48, 72, and 144 h after tracer administration. Blood-pool activity concentrations were obtained from regions of interest drawn on the heart on the planar images. Tumor and blood activity concentrations, scaled to therapeutic administered activities-both standard and myeloablative-were input into a geometry and tracking model (GEANT, version 4) of the aorta. The simulated energy deposited in the arterial walls was collected and fitted, and the AD and biologic effective dose values to the aortic wall and tumors were obtained for standard therapeutic and hypothetical myeloablative administered activities. RESULTS: Arterial wall ADs from standard therapy were lower (0.6-3.7 Gy) than those typical from external-beam therapy, as were the tumor ADs (1.4-10.5 Gy). The ratios of tumor AD to arterial wall AD were greater for radioimmunotherapy by a factor of 1.9-4.0. For myeloablative therapy, artery wall ADs were in general less than those typical for external-beam therapy (9.4-11.4 Gy for 3 of 4 patients) but comparable for 1 patient (32.6 Gy). CONCLUSION: Blood vessel radiation dose can be estimated using the software package 3D-RD combined with GEANT modeling. The dosimetry analysis suggested that arterial wall toxicity is highly unlikely in standard dose radioimmunotherapy but should be considered a potential concern and limiting factor in myeloablative therapy.
Resumo:
The numerous yeast genome sequences presently available provide a rich source of information for functional as well as evolutionary genomics but unequally cover the large phylogenetic diversity of extant yeasts. We present here the complete sequence of the nuclear genome of the haploid-type strain of Kuraishia capsulata (CBS1993(T)), a nitrate-assimilating Saccharomycetales of uncertain taxonomy, isolated from tunnels of insect larvae underneath coniferous barks and characterized by its copious production of extracellular polysaccharides. The sequence is composed of seven scaffolds, one per chromosome, totaling 11.4 Mb and containing 6,029 protein-coding genes, ~13.5% of which being interrupted by introns. This GC-rich yeast genome (45.7%) appears phylogenetically related with the few other nitrate-assimilating yeasts sequenced so far, Ogataea polymorpha, O. parapolymorpha, and Dekkera bruxellensis, with which it shares a very reduced number of tRNA genes, a novel tRNA sparing strategy, and a common nitrate assimilation cluster, three specific features to this group of yeasts. Centromeres were recognized in GC-poor troughs of each scaffold. The strain bears MAT alpha genes at a single MAT locus and presents a significant degree of conservation with Saccharomyces cerevisiae genes, suggesting that it can perform sexual cycles in nature, although genes involved in meiosis were not all recognized. The complete absence of conservation of synteny between K. capsulata and any other yeast genome described so far, including the three other nitrate-assimilating species, validates the interest of this species for long-range evolutionary genomic studies among Saccharomycotina yeasts.
Resumo:
BACKGROUND: Candida glabrata follows C. albicans as the second or third most prevalent cause of candidemia worldwide. These two pathogenic yeasts are distantly related, C. glabrata being part of the Nakaseomyces, a group more closely related to Saccharomyces cerevisiae. Although C. glabrata was thought to be the only pathogenic Nakaseomyces, two new pathogens have recently been described within this group: C. nivariensis and C. bracarensis. To gain insight into the genomic changes underlying the emergence of virulence, we sequenced the genomes of these two, and three other non-pathogenic Nakaseomyces, and compared them to other sequenced yeasts. RESULTS: Our results indicate that the two new pathogens are more closely related to the non-pathogenic N. delphensis than to C. glabrata. We uncover duplications and accelerated evolution that specifically affected genes in the lineage preceding the group containing N. delphensis and the three pathogens, which may provide clues to the higher propensity of this group to infect humans. Finally, the number of Epa-like adhesins is specifically enriched in the pathogens, particularly in C. glabrata. CONCLUSIONS: Remarkably, some features thought to be the result of adaptation of C. glabrata to a pathogenic lifestyle, are present throughout the Nakaseomyces, indicating these are rather ancient adaptations to other environments. Phylogeny suggests that human pathogenesis evolved several times, independently within the clade. The expansion of the EPA gene family in pathogens establishes an evolutionary link between adhesion and virulence phenotypes. Our analyses thus shed light onto the relationships between virulence and the recent genomic changes that occurred within the Nakaseomyces.
Resumo:
La globalisation croissante du monde économique suscite un vif débat dans la sociologie des élites. Certains postulent l'émergence d'une classe capitaliste transnationale homogène, tandis que d'autres affirment la persistance de spécificités nationales dans le processus de formation des dirigeants d'entreprises. Pour situer le cas suisse dans ce débat, cet article compare le profil des dirigeants des 110 plus grandes firmes helvétiques en 1980 et en 2000. Les résultats montrent un fort processus d'internationalisation (hausse du nombre d'étrangers) et une modification des profils de formation (augmentation des Masters in Business Administration). La globalisation ne signifie pas pour autant une standardisation des profils puisqu'on observe une grande diversité des parcours professionnels et la persistance de formes de légitimité spécifiques au contexte helvétique.
Resumo:
BACKGROUND: Waterproofing agents are widely applied to leather and textile garments; they are also used as floor stain protectors by professionals. Acute respiratory injury is described in three cases of young healthy adults following occupational inhalation of a new waterproofing formulation containing an acrylate fluoropolymer. Within 1 or 2 h after exposure they developed a rapidly progressive dyspnoea; two of them had hypoxaemia and flu-like reactions. All patients improved with supportive treatment in a few days. The mechanism of toxicity is still under investigation, but experimental data suggest the role of this new acrylate fluoropolymer. CONCLUSION: Tilers should be warned against spraying floor stain repellents; there is also a need to make consumers aware that the spraying of waterproofing agents in a closed environment and concomitant smoking should be avoided.
Resumo:
BACKGROUND: Reading volume and mammography screening performance appear positively correlated. Quality and effectiveness were compared across low-volume screening programmes targeting relatively small populations and operating under the same decentralised healthcare system. Except for accreditation of 2nd readers (restrictive vs non-restrictive strategy), these organised programmes had similar screening regimen/procedures and duration, which maximises comparability. Variation in performance and its determinants were explored in order to improve mammography practice and optimise screening performance. METHODS: Circa 200,000 screens performed between 1999 and 2006 (4 rounds) in 3 longest standing Swiss cantonal programmes (of Vaud, Geneva and Valais) were assessed. Indicators of quality and effectiveness were assessed according to European standards. Interval cancers were identified through linkage with cancer registries records. RESULTS: Swiss programmes met most European standards of performance with a substantial, favourable cancer stage shift. Up to a two-fold variation occurred for several performance indicators. In subsequent rounds, compared with programmes (Vaud and Geneva) that applied a restrictive selection strategy for 2nd readers, proportions of in situ lesions and of small cancers (≤1cm) were one third lower and halved, respectively, and the proportion of advanced lesions (stage II+) nearly 50% higher in the programme without a restrictive selection strategy. Discrepancy in second-year proportional incidence of interval cancers appears to be multicausal. CONCLUSION: Differences in performance could partly be explained by a selective strategy for second readers and a prior experience in service screening, but not by the levels of opportunistic screening and programme attendance. This study provides clues for enhancing mammography screening performance in low-volume programmes.